Share

|

|

|

Four distinct Kawasaki disease subgroups identified

Distinct subgroups exist among children with Kawasaki disease, say researchers in findings that provide some clues to the clinical variability of the disease.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Second primary malignancy risk after lymphoma chemotherapy and HSCT determined

Danish researchers have quantified the risk of second primary malignancy in patients with lymphoma who are treated with high-dose chemotherapy and autologous haematopoietic stem-cell transplantation.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Base-edited CAR T-cell therapy shows promise for relapsed, refractory childhood ALL

T-Cells Work to Fight Cancer

Base-edited chimeric antigen receptor T-cell therapy is feasible for the treatment of relapsed or refractory childhood T-cell acute lymphoblastic leukemia, suggests research published in The New England Journal of Medicine.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Add-on tofacitinib shows treatment promise in SSc-ILD

The addition of tofacitinib to conventional disease-modifying antirheumatic drugs could help alleviate sclerosis in patients with systemic sclerosis-associated interstitial lung disease, suggests research.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Cortical gyrification a possible early biomarker for PD progression

Researchers have found reductions in cortical gyrifications in patients with newly diagnosed Parkinson’s disease that worsen over time and may therefore serve as a potential biomarker for disease progression.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.